These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11269750)

  • 1. Correction formula for carbamylated haemoglobin in diabetic uraemic patients.
    Hammouda AM; Mady GE
    Ann Clin Biochem; 2001 Mar; 38(Pt 2):115-9. PubMed ID: 11269750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamylated haemoglobin in normal, diabetic and uraemic patients.
    Kwan JT; Carr EC; Barron JL; Bending MR
    Ann Clin Biochem; 1992 Mar; 29 ( Pt 2)():206-9. PubMed ID: 1626926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors determining hemoglobin carbamylation in renal failure.
    Stim J; Shaykh M; Anwar F; Ansari A; Arruda JA; Dunea G
    Kidney Int; 1995 Nov; 48(5):1605-10. PubMed ID: 8544421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of carbamylated haemoglobin in acute renal failure.
    Wynckel A; Randoux C; Millart H; Desroches C; Gillery P; Canivet E; Chanard J
    Nephrol Dial Transplant; 2000 Aug; 15(8):1183-8. PubMed ID: 10910442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylated haemoglobin in uraemia.
    Paisey R; Banks R; Holton R; Young K; Hopton M; White D; Hartog M
    Diabet Med; 1986; 3(5):445-8. PubMed ID: 2435450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated and carbamylated haemoglobin in uraemia.
    Smith WG; Holden M; Benton M; Brown CB
    Nephrol Dial Transplant; 1989; 4(2):96-100. PubMed ID: 2496361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor haemoglobin fractions in uraemic and in diabetic patients.
    Lantz B; Wajcman H; Beaufils M; Meyrier A; Labie D; Assan R
    Diabete Metab; 1981 Jun; 7(2):109-14. PubMed ID: 6788617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis.
    Kalim S; Trottier CA; Wenger JB; Wibecan J; Ahmed R; Ankers E; Karumanchi SA; Thadhani R; Berg AH
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1809-1816. PubMed ID: 27445162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamylation and glycosylation of haemoglobin in vitro: effects of cyanate and glucose.
    Ationu A
    Med Lab Sci; 1992 Mar; 49(1):34-7. PubMed ID: 1453906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemoglobin A₁c measurement in patients with chronic kidney disease.
    Li Q; Ju Y; Jin T; Pang B; Deng J; Du T; Wang H
    Clin Biochem; 2014 Apr; 47(6):481-4. PubMed ID: 24362265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamylation is a competitor of glycation for protein modification in vivo.
    Nicolas C; Jaisson S; Gorisse L; Tessier FJ; Niquet-Léridon C; Jacolot P; Pietrement C; Gillery P
    Diabetes Metab; 2018 Mar; 44(2):160-167. PubMed ID: 28690125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific affinity-chromatographic measurement of glycated hemoglobins in uremic patients.
    Bruns DE; Lobo PI; Savory J; Wills MR
    Clin Chem; 1984 Apr; 30(4):569-71. PubMed ID: 6705201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonenzymatic glycosylation of hemoglobin and total plasmatic proteins in end-stage renal disease.
    Sabater J; Quereda C; Herrera I; Pascual J; Villafruela JJ; Ortuño J
    Am J Nephrol; 1991; 11(1):37-43. PubMed ID: 2048577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of haemoglobin carbamylation in haemodialysis and peritoneal dialysis patients.
    Kairaitis LK; Yuill E; Harris DC
    Nephrol Dial Transplant; 2000 Sep; 15(9):1431-7. PubMed ID: 10978403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fructosamines in uraemia and renal replacement therapy.
    Beardsworth SF; Vernon V; Harrison D
    Nephrol Dial Transplant; 1989; 4(8):748-9. PubMed ID: 2510086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamylated haemoglobin in chronic renal failure.
    Smith WG; Holden M; Benton M; Brown CB
    Clin Chim Acta; 1988 Dec; 178(3):297-303. PubMed ID: 3240603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of acute from chronic renal impairment by detection of carbamylated haemoglobin.
    Davenport A; Jones SR; Goel S; Astley JP; Hartog M
    Lancet; 1993 Jun; 341(8861):1614-7. PubMed ID: 8099989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamylated hemoglobin as a therapeutic marker in hemodialysis.
    Hasuike Y; Nakanishi T; Maeda K; Tanaka T; Inoue T; Takamitsu Y
    Nephron; 2002 Jun; 91(2):228-34. PubMed ID: 12053058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure.
    Morgan L; Marenah CB; Jeffcoate WJ; Morgan AG
    Diabet Med; 1996 Jun; 13(6):514-9. PubMed ID: 8799653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.